Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Characterization of Tn5801.Sag, a variant of Staphylococcus aureus Tn916 family transposon Tn5801 that is widespread in clinical isolates of Streptococcus agalactiae.

Mingoia M, Morici E, Tili E, Giovanetti E, Montanari MP, Varaldo PE.

Antimicrob Agents Chemother. 2013 Sep;57(9):4570-4. doi: 10.1128/AAC.00521-13. Epub 2013 Jul 1.

2.

Heterogeneity of Tn5253-like composite elements in clinical Streptococcus pneumoniae isolates.

Mingoia M, Tili E, Manso E, Varaldo PE, Montanari MP.

Antimicrob Agents Chemother. 2011 Apr;55(4):1453-9. doi: 10.1128/AAC.01087-10. Epub 2011 Jan 24.

3.

Genetic elements responsible for erythromycin resistance in streptococci.

Varaldo PE, Montanari MP, Giovanetti E.

Antimicrob Agents Chemother. 2009 Feb;53(2):343-53. doi: 10.1128/AAC.00781-08. Epub 2008 Nov 10. Review. No abstract available.

4.

Effects of fluoroquinolones on bacterial adhesion and on preformed biofilm of strains isolated from urinary double J stents.

Minardi D, Montanari MP, Tili E, Cochetti I, Mingoia M, Varaldo PE, Muzzonigro G.

J Chemother. 2008 Apr;20(2):195-201.

PMID:
18467245
5.

erm(B)-carrying elements in tetracycline-resistant pneumococci and correspondence between Tn1545 and Tn6003.

Cochetti I, Tili E, Mingoia M, Varaldo PE, Montanari MP.

Antimicrob Agents Chemother. 2008 Apr;52(4):1285-90. doi: 10.1128/AAC.01457-07. Epub 2008 Feb 19.

6.

Expressed and unexpressed tet(M) genes and the erm(B)-carrying Tn1116 transposon in Streptococcus pyogenes and Streptococcus pneumoniae.

Giovanetti E, Brenciani A, Bacciaglia A, Montanari MP, Varaldo PE.

Antimicrob Agents Chemother. 2007 Dec;51(12):4535; author reply 4535-6. No abstract available.

7.

Composite structure of Streptococcus pneumoniae containing the erythromycin efflux resistance gene mefI and the chloramphenicol resistance gene catQ.

Mingoia M, Vecchi M, Cochetti I, Tili E, Vitali LA, Manzin A, Varaldo PE, Montanari MP.

Antimicrob Agents Chemother. 2007 Nov;51(11):3983-7. Epub 2007 Aug 20.

8.

New Tn916-related elements causing erm(B)-mediated erythromycin resistance in tetracycline-susceptible pneumococci.

Cochetti I, Tili E, Vecchi M, Manzin A, Mingoia M, Varaldo PE, Montanari MP.

J Antimicrob Chemother. 2007 Jul;60(1):127-31. Epub 2007 May 5.

PMID:
17483548
9.

Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I).

Cochetti I, Vecchi M, Mingoia M, Tili E, Catania MR, Manzin A, Varaldo PE, Montanari MP.

Antimicrob Agents Chemother. 2005 Dec;49(12):4999-5006.

10.

Analysis of the beta-lactamase plasmid of borderline methicillin-susceptible Staphylococcus aureus: focus on bla complex genes and cadmium resistance determinants cadD and cadX.

Massidda O, Mingoia M, Fadda D, Whalen MB, Montanari MP, Varaldo PE.

Plasmid. 2006 Mar;55(2):114-27. Epub 2005 Oct 17.

PMID:
16229889
11.

Synergistic potential of ceftazidime plus amikacin or levofloxacin against Pseudomonas aeruginosa as determined using a checkerboard and a disk diffusion technique.

Montanari MP, Piccoli L, Mingoia M, Marchetti F, Varaldo PE.

Diagn Microbiol Infect Dis. 2005 Oct;53(2):157-60. Epub 2005 Sep 15.

PMID:
16168614
12.
13.

Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002).

Marchese A, Gualco L, Cochetti I, Montanari MP, Speciale AM, Musumeci SR, Varaldo PE, Nicoletti G, Schito GC.

Int J Antimicrob Agents. 2005 Aug;26(2):138-45.

PMID:
16024234
14.

Interpretive criteria for disk diffusion susceptibility testing of ulifloxacin, the active metabolite of prulifloxacin.

Montanari MP, Ferrante L, Tili E, Cochetti I, Rossi V, Varaldo PE.

J Chemother. 2005 Apr;17(2):138-42.

PMID:
15920898
15.

Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy.

Montanari MP, Tili E, Cochetti I, Mingoia M, Manzin A, Varaldo PE.

Microb Drug Resist. 2004 Fall;10(3):209-17.

PMID:
15383164
16.

Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae.

Montanari MP, Cochetti I, Mingoia M, Varaldo PE.

Antimicrob Agents Chemother. 2003 Jul;47(7):2236-41.

17.

Phenotypes and genotypes of erythromycin-resistant pneumococci in Italy.

Montanari MP, Mingoia M, Cochetti I, Varaldo PE.

J Clin Microbiol. 2003 Jan;41(1):428-31.

18.
19.

SmaI macrorestriction analysis of Italian isolates of erythromycin-resistant Streptococcus pyogenes and correlations with macrolide-resistance phenotypes.

Ripa S, Zampaloni C, Vitali LA, Giovanetti E, Montanari MP, Prenna M, Varaldo PE.

Microb Drug Resist. 2001 Spring;7(1):65-71.

PMID:
11310805
20.

Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.

Montanari MP, Mingoia M, Giovanetti E, Varaldo PE.

J Clin Microbiol. 2001 Apr;39(4):1311-5.

21.
22.

In vitro activity of levofloxacin against gram-positive bacteria.

Montanari MP, Mingoia M, Marchetti F, Varaldo PE.

Chemotherapy. 1999 Nov-Dec;45(6):411-7.

PMID:
10567771
23.

Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.

Giovanetti E, Montanari MP, Mingoia M, Varaldo PE.

Antimicrob Agents Chemother. 1999 Aug;43(8):1935-40.

24.

Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin.

Prenna M, Montanari MP, Mingoia M, Biavasco F, Ripa S, Varaldo PE.

Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):816-9. No abstract available.

PMID:
9923533
25.

In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.

Montanari MP, Prenna M, Mingoia M, Ripa S, Varaldo PE.

Chemotherapy. 1998 Mar-Apr;44(2):85-93.

PMID:
9551237
26.
27.

Borderline susceptibility to methicillin in Staphylococcus aureus: a new mechanism of resistance?

Montanari MP, Massidda O, Mingoia M, Varaldo PE.

Microb Drug Resist. 1996 Summer;2(2):257-60. Review.

PMID:
9158769
28.

Cloning and expression of the penicillinase from a borderline methicillin-susceptible Staphylococcus aureus strain in Escherichia coli.

Massidda O, Montanari MP, Mingoia M, Varaldo PE.

FEMS Microbiol Lett. 1994 Jun 15;119(3):263-9. Erratum in: FEMS Microbiol Lett 1994 Aug 1;121(1):131.

PMID:
8050709
29.

Survey of clinical isolates of Staphylococcus aureus for borderline susceptibility to antistaphylococcal penicillins.

Varaldo PE, Montanari MP, Biavasco F, Manso E, Ripa S, Santacroce F.

Eur J Clin Microbiol Infect Dis. 1993 Sep;12(9):677-82.

PMID:
8243483
30.
32.

Gram-positive infections: epidemiological aspects and trends of antibiotic resistance.

Varaldo PE, Biavasco F, Montanari MP, Facinelli B.

J Chemother. 1991 Jan;3 Suppl 1:158-62. Review. No abstract available.

PMID:
12041754
33.

Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species.

Biavasco F, Giovanetti E, Montanari MP, Lupidi R, Varaldo PE.

J Antimicrob Chemother. 1991 Jan;27(1):71-9.

PMID:
1828799
34.

Further characterization of borderline methicillin-resistant Staphylococcus aureus and analysis of penicillin-binding proteins.

Montanari MP, Tonin E, Biavasco F, Varaldo PE.

Antimicrob Agents Chemother. 1990 May;34(5):911-3.

35.

Preliminary study of breastfeeding and bacterial adhesion to uroepithelial cells.

Coppa GV, Gabrielli O, Giorgi P, Catassi C, Montanari MP, Varaldo PE, Nichols BL.

Lancet. 1990 Mar 10;335(8689):569-71.

PMID:
1968576
36.

Evaluation of spontaneous resistance to glycopeptide antibiotics in staphylococcal populations.

Biavasco F, Montanari MP, Facinelli B, Varaldo PE.

J Chemother. 1989 Jul;1(4 Suppl):389-90. No abstract available.

PMID:
16312453
37.

Effects of beta-lactamase inhibitors on Staphylococcus aureus susceptibility to penicillin G and penicillinase-resistant penicillins.

Montanari MP, Varaldo PE.

J Chemother. 1989 Jul;1(4 Suppl):344-5. No abstract available.

PMID:
16312431
38.

Antibiotic resistance, beta-lactamase activity, and plasmid content in strains of Haemophilus and Branhamella isolated from children.

Facinelli B, Montanari MP, Ratsch I, Brescia A, Oggiano N, Giorgi PL, Varaldo PE.

J Chemother. 1989 Jul;1(4 Suppl):301. No abstract available.

PMID:
16312410
39.

Plasmid deoxyribonucleic acid in throat and cerebrospinal fluid isolates of Neisseria meningitidis.

Facinelli B, Montanari MP, Piermattei P.

Eur J Epidemiol. 1987 Jun;3(2):206-8.

PMID:
3111881
40.

Heteroresistant and nonheteroresistant methicillin-resistant Staphylococcus aureus.

Varaldo PE, Biavasco F, Montanari MP.

J Clin Microbiol. 1987 Feb;25(2):463-4. No abstract available.

41.

Adherence of gram-negative uropathogens to human uroepithelial cells.

Polito M, Minardi D, Montanari MP, Varaldo PE.

Eur Urol. 1987;13(1-2):74-8.

PMID:
3107998
42.

Plasmid-specified aminoglycoside-modifying enzymes in clinical isolates of Klebsiella pneumoniae.

Facinelli B, Montanari MP, Calegari L.

Eur J Epidemiol. 1985 Mar;1(1):48-53.

PMID:
3021514
43.

[R factors in Proteus rettgeri strains].

Toni M, Somenzi P, Montanari MP.

Ann Sclavo. 1978 Mar-Apr;20(2):180-90. Italian. No abstract available.

PMID:
742932

Supplemental Content

Loading ...
Support Center